We demonstrate that obese MIF−/− mice have reduced hepatomegaly, lower systemic ALT levels and are partially protected from HFD-induced hepatic steatosis; coincident with reduced Pparγ and Srebp-1c mRNA expression compared to WT. The gene discussed is MIF; the disease is Hepatic steatosis.